NEW YORK, April 22, 2016 /PRNewswire-USNewswire/ -- American Skin Association (ASA) today announced the newest members of its Board of Directors, Gitte Aabo, President and Chief Executive Officer of LEO Pharma A/S, a global healthcare company dedicated to helping people achieve healthy skin, and Dr. George Cotsarelis, Chair, Department of Dermatology and Milton Bixler Hartzell Professor of Dermatology at the Perelman School of Medicine at the University of Pennsylvania and Director of the University of Pennsylvania Hair and Scalp Clinic.
Ms. Aabo has been President and CEO of LEO Pharma A/S since January of 2008 and has dedicated 24 years of her career to the global dermatology company. Ms. Aabo is internationally recognized as an inspirational leader with a strong focus on patients. As CEO, she has played a key role within the field of dermatology in highlighting the importance of understanding patient needs as it relates to delivering better care to people living with skin conditions.
Dr. Cotsarelis has served on the faculty of Perelman School of Medicine at the University of Pennsylvania since 1996. His research focuses on epithelial stem cells, hair follicle biology, epithelial carcinogenesis, wound healing and skin regeneration. Dr. Cotsarelis first pinpointed the location of corneal epithelial stem cells and hair follicle stem cells. His findings impacted corneal transplantation and have implications for developing cell-based treatments for hair loss and chronic wounds.
"I am delighted to welcome Ms. Aabo and Dr. Cotsarelis to ASA's Board of Directors. Both have exemplary records of success in their respective fields and will be tremendous additions to ASA as we fulfill our mission of improving the lives of individuals affected by skin cancer and diseases and raising the public consciousness about skin health. I look forward to their participation on our board," said Howard P. Milstein, Chairman of ASA's Board of Directors.
ABOUT LEO PHARMA
LEO Pharma helps people achieve healthy skin. By offering care solutions to patients in more than 100 countries globally, LEO Pharma supports people in managing their skin conditions. Founded in 1908 and owned by the LEO Foundation, the healthcare company has devoted decades of research and development to delivering products and solutions to people with skin conditions. LEO Pharma is headquartered in Denmark and employs around 5,000 people worldwide. For more information, visit www.leo-pharma.com
ABOUT AMERICAN SKIN ASSOCIATION
A unique collaboration of patients, families, advocates, physicians and scientists, ASA has evolved over nearly three decades as a leading force in efforts to defeat melanoma, skin cancer and other skin diseases. Established to serve the now more than 100 million Americans – one third of the U.S. population – afflicted with skin disorders, the organization's mission remains to: advance research, champion skin health – particularly among children, and drive public awareness about skin disease. For more information, visit americanskin.org.
American Skin Association is a Four-Star Charity Navigator rated foundation.
SOURCE American Skin Association